A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities

Thaddeus Wesley Warren Pace, Christine M. Heim

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8% in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.

Original languageEnglish (US)
Pages (from-to)6-13
Number of pages8
JournalBrain, Behavior, and Immunity
Volume25
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Psychoneuroimmunology
Post-Traumatic Stress Disorders
Comorbidity
Immune System Diseases
Lymphocyte Count
Veterans
Skin Tests
Natural Killer Cells
Glucocorticoids
Catecholamines

Keywords

  • Catecholamines
  • Glucocorticoids
  • Immune system
  • Inflammation
  • Neuroendocrine-immune interactions
  • PTSD
  • PTSD risk factors

ASJC Scopus subject areas

  • Immunology
  • Behavioral Neuroscience
  • Endocrine and Autonomic Systems

Cite this

@article{ae6ab4342e554b638e2ddda619ee7fb9,
title = "A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities",
abstract = "Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8{\%} in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.",
keywords = "Catecholamines, Glucocorticoids, Immune system, Inflammation, Neuroendocrine-immune interactions, PTSD, PTSD risk factors",
author = "Pace, {Thaddeus Wesley Warren} and Heim, {Christine M.}",
year = "2011",
month = "1",
doi = "10.1016/j.bbi.2010.10.003",
language = "English (US)",
volume = "25",
pages = "6--13",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - A short review on the psychoneuroimmunology of posttraumatic stress disorder

T2 - From risk factors to medical comorbidities

AU - Pace, Thaddeus Wesley Warren

AU - Heim, Christine M.

PY - 2011/1

Y1 - 2011/1

N2 - Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8% in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.

AB - Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8% in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.

KW - Catecholamines

KW - Glucocorticoids

KW - Immune system

KW - Inflammation

KW - Neuroendocrine-immune interactions

KW - PTSD

KW - PTSD risk factors

UR - http://www.scopus.com/inward/record.url?scp=78649324180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649324180&partnerID=8YFLogxK

U2 - 10.1016/j.bbi.2010.10.003

DO - 10.1016/j.bbi.2010.10.003

M3 - Article

C2 - 20934505

AN - SCOPUS:78649324180

VL - 25

SP - 6

EP - 13

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

IS - 1

ER -